Abstract
Objective Evaluate stability of spectral results at different heart rates, acquisition modes, and cardiac phases in first-generation clinical dual-source photon-counting CT (PCCT).
Materials and Methods A cardiac motion simulator with a coronary stenosis mimicking a 50% eccentric calcium plaque was scanned with a first-generation dual-source PCCT at five different heart rates (0, 60, 70, 80, 100 bpm). Scans were performed at 120 kVp with the three available cardiac scan modes (high pitch prospectively ECG-triggered spiral, prospectively ECG-triggered axial, retrospectively ECG-gated spiral). Subsequently, virtual monoenergetic images at 50, 70, and 150 keV and iodine density maps were reconstructed at both diastole and systole to investigate the effect of the cardiac phase. Full width half max (FWHM) of the stenosis, Dice score (DSC) for the stenosed region, and eccentricity of the non-stenosed region were analyzed.
Results FWHM exhibited average differences from the static FWHM across cardiac phase and heart rates of -0.20, -0.28, and -0.15 mm at VMI 150 keV for high pitch prospectively ECG-triggered spiral, prospectively ECG-triggered axial, and retrospectively ECG-gated spiral scans, respectively. DSC demonstrated similarity among parameters with standard deviations of 0.08, 0.09, 0.11, and 0.08 for VMI 50, 70, and 150 keV, and iodine density maps, respectively, with larger differences present at systole and with high pitch scans. Similarly, eccentricity illustrated small differences across heart rate and acquisition mode for each spectral result.
Conclusions Consistency of spectral results at different heart rates and acquisition modes for different cardiac phase demonstrates the added benefit of spectral results from PCCT to dual-source CT to further increase confidence in quantification and advance cardiovascular diagnostics.
Competing Interest Statement
The authors of this manuscript declare relationships with the following companies: Siemens Healthineers. Harold I. Litt and Peter B. Noël have a research agreement with Siemens Healthineers. Pooyan Sahbaee is an employee of Siemens Healthineers.
Funding Statement
We acknowledge support through the National Institutes of Health (R01EB030494) and Siemens Healthineers.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Source of Support: Siemens Healthineers
Data Availability
All data produced in the study are available upon reasonable request to the authors.
